Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment
NCT ID: NCT00404209
Last Updated: 2024-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
10 participants
INTERVENTIONAL
2007-03-31
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
NCT00407108
Perfluorocarbon Liquid vs. Posterior Retinotomy During Pars-plana Vitrectomy for Rhegmatogenous Retinal Detachment
NCT06919211
Comparison High-density Silicone Oils in Retinal Detachment
NCT00403702
Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy
NCT03660384
Pneumovitreolysis for Vitreomacular Traction
NCT03945695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitrectomy
pressurized 23GA vitrectomy with a 3D system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación para Evitar la Ceguera en México
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asociacion para evitar la ceguera en Mexico
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugo Quiroz-Mercado, MD
Role: PRINCIPAL_INVESTIGATOR
Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"
Raul Velez-Montoya, MD
Role: PRINCIPAL_INVESTIGATOR
Asociación para Evitar la Ceguera en México
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes"
Mexico City, Mexico DF, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APEC-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.